VIR - Vir Biotechnology, Inc.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $-0.67
|
Rev Est: $2.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.67
DETAILS
HIGH:
$30.00
LOW:
$15.00
MEDIAN:
$18.50
CONSENSUS:
$20.67
UPSIDE:
117.81%
Market Cap:
1.32B
Volume:
37,489,111
Avg Volume:
1,853,726
52 Week Range:
4.155-10.29
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.69
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
408
IPO Date:
2019-10-11
EPS (TTM):
-3.16
P/E Ratio:
-1.91
Revenue (TTM):
68.56M
Total Assets:
1.00B
Total Debt:
89.05M
Cash & Equiv:
234.11M
Rev Growth (5Y):
0.4%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-23 | $-0.31 | $-0.42 | +26.6% | $64.1M | $19.9M | +221.9% |
| 2025-11-05 | $-1.17 | $-0.70 | -67.1% | $240000 | $19.9M | -98.8% |
| 2025-08-06 | $-0.80 | $-0.72 | -11.1% | $1.2M | $2.7M | -55.4% |
| 2025-05-07 | $-0.88 | $-0.83 | -6.0% | $1.8M | $8.6M | -79.1% |
| 2025-02-26 | $-0.76 | $-0.85 | +10.6% | $12.4M | $8.1M | +52.0% |
| 2024-10-31 | $-1.56 | $-0.96 | -62.5% | $2.4M | $9.4M | -74.6% |
| 2024-08-01 | $-1.02 | $-0.93 | -9.7% | $3.1M | $7.5M | -59.0% |
| 2024-05-02 | $-0.48 | $-0.99 | +51.5% | $56.4M | $11.7M | +381.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 68.56M | 74.20M | 86.18M | 1.62B | 1.10B | 67.25M | 711,000 | 868,000 | 149,000 |
| Net Income | (437.99M) | (521.96M) | (615.06M) | 515.84M | 528.58M | (298.67M) | (174.68M) | (115.88M) | (69.85M) |
| EPS | -3.16 | -3.83 | -4.59 | 3.89 | 4.07 | -2.51 | -1.62 | -1.20 | -10.02 |
| Total Assets | 1.00B | 1.40B | 1.92B | 2.80B | 1.95B | 918.76M | 512.07M | 191.60M | 251.57M |
| Total Debt | 89.05M | 97.89M | 124.54M | 127.97M | 137.49M | 70.18M | 237,000 | 10.14M | 0 |
| Cash & Equivalents | 234.11M | 222.95M | 241.58M | 848.63M | 347.81M | 436.57M | 109.33M | 47.60M | 187.92M |
| Operating Cash Flow | (391.78M) | (446.35M) | (778.78M) | 1.66B | (47.59M) | (190.94M) | (129.63M) | (94.10M) | (66.38M) |
| Free Cash Flow | (391.78M) | (453.65M) | (800.36M) | 1.60B | (69.41M) | (197.49M) | (138.57M) | (102.29M) | (69.12M) |
| FCF per Share | -2.83 | -3.33 | -5.97 | 12.03 | -0.53 | -1.66 | -1.29 | -1.06 | -9.91 |
| Book Value | 765.28M | 1.15B | 1.59B | 2.08B | 1.43B | 716.85M | 423.94M | (179.18M) | (68.92M) |
| Cash & ST Investments | 462.86M | 905.35M | 1.52B | 2.40B | 708.14M | 736.86M | 383.44M | 98.44M | 187.92M |
| ROC Equity | -0.57 | -0.45 | -0.39 | 0.25 | 0.37 | -0.42 | -0.41 | N/A | N/A |